2018
DOI: 10.1038/s41467-018-06638-8
|View full text |Cite|
|
Sign up to set email alerts
|

A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis

Abstract: Mechanisms that limit thrombosis are poorly defined. One of the few known endogenous platelet inhibitors is nitric oxide (NO). NO activates NO sensitive guanylyl cyclase (NO-GC) in platelets, resulting in an increase of cyclic guanosine monophosphate (cGMP). Here we show, using cGMP sensor mice to study spatiotemporal dynamics of platelet cGMP, that NO-induced cGMP production in pre-activated platelets is strongly shear-dependent. We delineate a new mode of platelet-inhibitory mechanotransduction via shear-act… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
42
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 33 publications
(43 citation statements)
references
References 44 publications
1
42
0
Order By: Relevance
“…NO is known to increase the production of cGMP by activating NO sensitive guanylyl cyclase (NO-GC) in platelets. This effect could cause cGMP production with the increase of activated NO-GC, promoting thrombolysis [24]. In line with the results of this experiment, it was confirmed that isoscopoletin significantly increased cGMP production, possibly resulting from an increase in NO by isoscopoletin.…”
Section: Discussionsupporting
confidence: 88%
“…NO is known to increase the production of cGMP by activating NO sensitive guanylyl cyclase (NO-GC) in platelets. This effect could cause cGMP production with the increase of activated NO-GC, promoting thrombolysis [24]. In line with the results of this experiment, it was confirmed that isoscopoletin significantly increased cGMP production, possibly resulting from an increase in NO by isoscopoletin.…”
Section: Discussionsupporting
confidence: 88%
“…It was later shown that the movement of CD3 to CD4 biosensor; a cGMP biosensor is shown as an example. cGi500 (Russwurm et al, 2007) is a cGMP indicator consisting of the engineered cGMP-binding domain of the cGMP-dependent protein kinase type I (gray) sandwiched between CFP and YFP (Wen et al, 2018). The energy transfer occurs from excited CFP to YFP.…”
Section: Fret Imagingmentioning
confidence: 99%
“…An emerging trend is to do this using intravital imaging; this has been facilitated by recent advances in the development of improved FRET biosensors with high FRET efficiency, good specificity and excellent response kinetics (Bajar et al, 2016;Greenwald et al, 2018;Lam et al, 2012). Mice have been engineered to express FRET-based biosensors, and intravital FRET imaging has been applied to study signaling molecules, such as cGMP (Thunemann et al, 2013;Wen et al, 2018), cAMP (Sprenger et al, 2015), Ca 2+ (Yang et al, 2018), protein kinase A (PKA) and extracellular signal-regulated kinase 1/2 (ERK1/2) activity (Mizuno et al, 2014).…”
Section: Flim-fretmentioning
confidence: 99%
“…Sensors for cGMP were developed behind cAMP sensors because of the lower cGMP abundance in most cell types. However, several cGMP sensors are now well developed for monitoring intracellular cGMP [ 44 , 45 , 46 ].…”
Section: Introduction To Cyclic Nucleotides and Signal Transductiomentioning
confidence: 99%